SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Savant Don

(Last) (First) (Middle)
12582 WEST MILLENNIUM

(Street)
LOS ANGELES CA 90094

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
IMAX CORP [ IMAX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
President, Global Sales
3. Date of Earliest Transaction (Month/Day/Year)
03/07/2017
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
common shares (opening balance) 0 D
common shares 03/07/2017 M 1,531(1) A $0.00 1,531 D
common shares 03/08/2017 S 576(2) D $32.2649 955 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
restricted share units(3) (4) 03/07/2017 A 7,512 (5) 01/01/2021 common shares 7,512 (4) 7,512 D
stock options (to buy) $32.45 03/07/2017 A 9,109 (6) 03/07/2024 common shares 9,109 $32.45 9,109 D
restricted share units $0.00(1) 03/07/2017 M 1,531(1) 03/07/2017 12/01/2017 common shares 1,531 $0.00(1) 6,122(7) D
Explanation of Responses:
1. Represents the conversion upon vesting of restricted share units into common shares. Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation.
2. Mr. Savant is reporting the sale of common shares to satisfy his tax withholding obligations in connection with the delivery of common shares upon conversion of the restricted share unit
3. Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation.
4. Each restricted share unit is the economic equivalent of one common share of IMAX Corporation.
5. The restricted share units vest and will be converted to common shares in four installments 1,502 on March 7, 2018; 1,878 on each of March 7, 2019 and March 7, 2020 and 2,254 on December 1, 2020.
6. The stock options become exercisable in four installments: 1,822 on March 7, 2018, 2,277 on each of March 7, 2019 and March 7, 2020 and 2,733 on March 7, 2021.
7. This represents the number of restricted share units for this transaction only. Mr. Savant's aggregate remaining outstanding option, restricted share unit and common share balances following this transaction will be 24,590; 13,634 and 955 respectively.
Remarks:
Don Savant 03/09/2017
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.